相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis, and repurposing of O6-aminoalkyl-sulfuretin analogs towards discovery of potential lead compounds as antileishmanial agents
Ahmed H. E. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies
Ahmed H. E. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Regulation of acetylcholinesterase during the lipopolysaccharide-induced inflammatory responses in microglial cells
Yingjie Xia et al.
FASEB JOURNAL (2022)
6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment
Qing Song et al.
BIOORGANIC CHEMISTRY (2022)
Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases
Ahmed H. E. Hassan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer's Disease
Kazuyuki Takata et al.
MOLECULES (2022)
A monoamine oxidase B inhibitor ethyl ferulate suppresses microglia-mediated neuroinflammation and alleviates ischemic brain injury
Xinxin Zou et al.
FRONTIERS IN PHARMACOLOGY (2022)
Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies
Ahmed Elkamhawy et al.
BIOORGANIC CHEMISTRY (2021)
Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors
Tapan Behl et al.
MOLECULES (2021)
Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds
Ahmed K. Farag et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
The global burden of neurological disorders: translating evidence into policy
Valery L. Feigin et al.
LANCET NEUROLOGY (2020)
Rubrofusarin Attenuates Chronic Restraint Stress-Induced Depressive Symptoms
Jee Hyun Yi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches
Ahmed Karam Farag et al.
BIOORGANIC CHEMISTRY (2020)
Casticin ameliorates scopolamine-induced cognitive dysfunction in mice
Jaehoon Kim et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff et al.
CHEMICAL REVIEWS (2019)
Multi-targeting aurones with monoamine oxidase and amyloid-beta inhibitory activities: Structure-activity relationship and translating multi-potency to neuroprotection
Kok-Fui Liew et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Antiproliferative 3-deoxysphingomyelin analogs: Design, synthesis, biological evaluation and molecular docking of pyrrolidine-based 3-deoxysphingomyelin analogs as anticancer agents
Ahmed H. E. Hassan et al.
BIOORGANIC CHEMISTRY (2019)
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease
Jong-Hyun Park et al.
SCIENCE ADVANCES (2019)
Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators
Ahmed H. E. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Natural products hybrids: 3,5,4′-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells
Ahmed H. E. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-24(6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent
Ahmed Karam Farag et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson's Disease Mice
Aijuan Yan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
An expeditious entry to rare tetrahydroimidazo[1,5-c]pyrrolo[1,2-a] pyrimidin-7(8H)-ones: A single-step gateway synthesis of glochidine congeners
Jeong Moo Seo et al.
TETRAHEDRON (2019)
Chromenones as Multineurotargeting Inhibitors of Human Enzymes
Carina Lemke et al.
ACS OMEGA (2019)
Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
Haroon Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Synthetic 3′,4′-Dihydroxyflavone Exerts Anti-Neuroinflammatory Effects in BV2 Microglia and a Mouse Model
Namkwon Kim et al.
BIOMOLECULES & THERAPEUTICS (2018)
Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors
Maude Giroud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives
Guillaume Dorothee
JOURNAL OF NEURAL TRANSMISSION (2018)
Construction of 8-Azabicyclo[3.2.1]octanes via Sequential DDQ-Mediated Oxidative Mannich Reactions of N-Aryl Pyrrolidines
Hanbyeol Jo et al.
ORGANIC LETTERS (2018)
Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex
Maa O. Quartey et al.
FRONTIERS IN NEUROSCIENCE (2018)
Probing the cholinergic system to understand neurodegenerative diseases
Pierre-Yves Renard et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
Sophia Schedin-Weiss et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Monoamine Oxidase B Inhibitors in Parkinson's Disease
Livia Dezsi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery
Andrea Milelli et al.
DRUG DEVELOPMENT RESEARCH (2016)
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors
Ji Won Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors
Young Hun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
A New Golden Age of Natural Products Drug Discovery
Ben Shen
CELL (2015)
Blood-brain barrier permeable anticholinesterase aurones: Synthesis, structure-activity relationship, and drug-like properties
Kok-Fui Liew et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
The re-emergence of natural products for drug discovery in the genomics era
Alan L. Harvey et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
Gennaro Pagano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
Zhiyou Cai
MOLECULAR MEDICINE REPORTS (2014)
The effects of a standardized Acanthopanax koreanum extract on stress-induced behavioral alterations in mice
Jun Man Jung et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival
Makoto Naoi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective
Erik H. F. Wong et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Aiming for the Ideal Synthesis
Tanja Gaich et al.
JOURNAL OF ORGANIC CHEMISTRY (2010)
Integrated Metabolite and Transcript Profiling Identify a Biosynthetic Mechanism for Hispidol in Medicago truncatula Cell Cultures
Mohamed A. Farag et al.
PLANT PHYSIOLOGY (2009)
Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors
Se-Young Son et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeting acetylcholinesterase to treat neurodegeneration
Ulrike Holzgrabe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Multifunctional drugs with different CNS targets for neuropsychiatric disorders
Cornelis J. Van der Schyf et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Gomisin A improves scopolamine-induced memory impairment in mice
Dong Hyun Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Monoamine oxidase-B inhibition in Alzheimer's disease
P Riederer et al.
NEUROTOXICOLOGY (2004)
Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: An ab initio QM/MM study
YK Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
C Binda et al.
NATURE STRUCTURAL BIOLOGY (2002)
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
P Foley et al.
PARKINSONISM & RELATED DISORDERS (2000)
分享论文
